Aggrenox®

ESPRIT (European/Australasian Stroke Prevention in Reversible Ischaemia Trial)

Results

Time-to-Event Curves

The following figure shows the time-to-event curves for the primary outcome event and for ischaemic events. In the on-treatment analysis, the HR for the primary outcome event was 0.82.

Time-to-Event Curves for Primary Outcome Event and all Ischaemic Events